CHA Biotech Co. Ltd (085660) - Cash Flow Conversion Efficiency

Latest as of June 2026: 0.000x

Based on the latest financial reports, CHA Biotech Co. Ltd (085660) has a cash flow conversion efficiency ratio of 0.000x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-208.26 Million ≈ $-141.14K USD) by net assets (₩1.03 Trillion ≈ $695.85 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see CHA Biotech Co. Ltd (085660) total market value for the company's overall valuation and market capitalisation.

CHA Biotech Co. Ltd - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how CHA Biotech Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

CHA Biotech Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CHA Biotech Co. Ltd ranked by their cash flow conversion efficiency. Explore 085660 operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
SAMPYO Cement Co. Ltd KQ:038500	0.061x
Xiamen Red Phase Instruments Inc SHE:300427	0.027x
Yingde Greatchem Chemicals Co. Ltd. A SHE:300804	N/A
Beijing Jingyeda Technology Co Ltd SHE:003005	-0.012x
Amper S.A. MC:AMP	-0.602x
CREDIT CORP. GROUP LTD. F:2RC	N/A
CapitaLand Malaysia Mall Trust KLSE:5180	0.021x
Lanzhou Greatwall Electrical Co Ltd SHG:600192	-0.019x

Annual Cash Flow Conversion Efficiency for CHA Biotech Co. Ltd (2009–2025)

The table below shows the annual cash flow conversion efficiency of CHA Biotech Co. Ltd from 2009 to 2025. View 085660 stock price and chart for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩809.25 Billion ≈ $548.42 Million	₩-72.52 Billion ≈ $-49.15 Million	-0.090x	+48.51%
2024-12-31	₩284.69 Billion ≈ $192.93 Million	₩-49.55 Billion ≈ $-33.58 Million	-0.174x	-1092.29%
2023-12-31	₩656.33 Billion ≈ $444.79 Million	₩11.51 Billion ≈ $7.80 Million	0.018x	+124.80%
2022-12-31	₩291.73 Billion ≈ $197.70 Million	₩-20.63 Billion ≈ $-13.98 Million	-0.071x	-245.08%
2021-12-31	₩456.06 Billion ≈ $309.06 Million	₩22.23 Billion ≈ $15.06 Million	0.049x	-63.17%
2020-12-31	₩355.09 Billion ≈ $240.64 Million	₩47.00 Billion ≈ $31.85 Million	0.132x	+97.78%
2019-12-31	₩377.18 Billion ≈ $255.61 Million	₩25.24 Billion ≈ $17.10 Million	0.067x	-70.97%
2018-12-31	₩326.99 Billion ≈ $221.60 Million	₩75.38 Billion ≈ $51.09 Million	0.231x	+342.94%
2017-12-31	₩230.74 Billion ≈ $156.37 Million	₩12.01 Billion ≈ $8.14 Million	0.052x	+31.95%
2016-12-31	₩286.32 Billion ≈ $194.04 Million	₩11.29 Billion ≈ $7.65 Million	0.039x	-81.50%
2015-12-31	₩290.10 Billion ≈ $196.60 Million	₩61.86 Billion ≈ $41.92 Million	0.213x	+3732.73%
2014-12-31	₩437.45 Billion ≈ $296.46 Million	₩-2.57 Billion ≈ $-1.74 Million	-0.006x	-104.53%
2013-12-31	₩512.34 Billion ≈ $347.21 Million	₩66.35 Billion ≈ $44.97 Million	0.130x	-6.23%
2012-12-31	₩331.41 Billion ≈ $224.59 Million	₩45.77 Billion ≈ $31.02 Million	0.138x	+13.63%
2011-12-31	₩285.46 Billion ≈ $193.45 Million	₩34.69 Billion ≈ $23.51 Million	0.122x	-54.29%
2010-12-31	₩158.24 Billion ≈ $107.24 Million	₩42.07 Billion ≈ $28.51 Million	0.266x	+39.05%
2009-12-31	₩125.61 Billion ≈ $85.12 Million	₩24.02 Billion ≈ $16.28 Million	0.191x	--

About CHA Biotech Co. Ltd

KQ:085660 Korea Biotechnology

Market Cap

$493.32 Million

₩727.95 Billion KRW

Market Cap Rank

#12374 Global

#352 in Korea

Share Price

₩7830.00

Change (1 day)

-1.51%

52-Week Range

₩7830.00 - ₩23850.00

All Time High

₩40950.00